FR11C0007I2 - Composition pharmaceutique stabilisee a l'aide d'un agent de base - Google Patents
Composition pharmaceutique stabilisee a l'aide d'un agent de baseInfo
- Publication number
- FR11C0007I2 FR11C0007I2 FR11C0007C FR11C0007C FR11C0007I2 FR 11C0007 I2 FR11C0007 I2 FR 11C0007I2 FR 11C0007 C FR11C0007 C FR 11C0007C FR 11C0007 C FR11C0007 C FR 11C0007C FR 11C0007 I2 FR11C0007 I2 FR 11C0007I2
- Authority
- FR
- France
- Prior art keywords
- pharmaceutical composition
- basic agent
- composition stabilized
- stabilized
- basic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Enzymes And Modification Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35465495 | 1995-12-22 | ||
PCT/JP1996/003722 WO1997023200A1 (fr) | 1995-12-22 | 1996-12-20 | Composition pharmaceutique stabilisee a l'aide d'un agent de base |
Publications (2)
Publication Number | Publication Date |
---|---|
FR11C0007I1 FR11C0007I1 (fr) | 2011-04-22 |
FR11C0007I2 true FR11C0007I2 (fr) | 2012-03-16 |
Family
ID=18439011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR11C0007C Active FR11C0007I2 (fr) | 1995-12-22 | 2011-03-17 | Composition pharmaceutique stabilisee a l'aide d'un agent de base |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0814782B1 (fr) |
JP (1) | JP3276962B2 (fr) |
KR (1) | KR100348842B1 (fr) |
CN (1) | CN1137684C (fr) |
AT (1) | ATE228354T1 (fr) |
AU (1) | AU725622B2 (fr) |
CA (1) | CA2213608C (fr) |
CZ (1) | CZ288545B6 (fr) |
DE (2) | DE122011000014I1 (fr) |
DK (1) | DK0814782T3 (fr) |
ES (1) | ES2183023T3 (fr) |
FR (1) | FR11C0007I2 (fr) |
HU (1) | HU227798B1 (fr) |
IL (1) | IL121565A (fr) |
MX (1) | MX9706389A (fr) |
NO (2) | NO316724B1 (fr) |
NZ (1) | NZ324446A (fr) |
PL (1) | PL186907B1 (fr) |
PT (1) | PT814782E (fr) |
RU (1) | RU2142790C1 (fr) |
SI (1) | SI0814782T1 (fr) |
SK (1) | SK282991B6 (fr) |
TW (1) | TW436294B (fr) |
UA (1) | UA29513C2 (fr) |
WO (1) | WO1997023200A1 (fr) |
ZA (1) | ZA9610792B (fr) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO5140079A1 (es) * | 1998-10-14 | 2002-03-22 | Novartis Ag | Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo |
SI20109A (sl) * | 1998-12-16 | 2000-06-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Stabilna farmacevtska formulacija |
US6569461B1 (en) | 1999-03-08 | 2003-05-27 | Merck & Co., Inc. | Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors |
EP1036563A1 (fr) * | 1999-03-08 | 2000-09-20 | MERCK & CO. INC. | Formulations retard a usage oral de simvastatine sous forme ouverte d'acide dihydroxy, de ses sels ou de ses esters |
JP2002538202A (ja) * | 1999-03-08 | 2002-11-12 | メルク エンド カムパニー インコーポレーテッド | HMG−CoAレダクターゼ阻害剤のジヒドロキシオープンアシッド及びその塩 |
JP4048780B2 (ja) * | 1999-12-13 | 2008-02-20 | 株式会社豊田中央研究所 | キノリン誘導体化合物及び有機電界発光素子 |
GB0001621D0 (en) | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
USRE44578E1 (en) | 2000-04-10 | 2013-11-05 | Teva Pharmaceutical Industries, Ltd. | Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids |
US6242003B1 (en) | 2000-04-13 | 2001-06-05 | Novartis Ag | Organic compounds |
US6806290B2 (en) | 2000-06-09 | 2004-10-19 | Lek Pharmaceuticals D.D. | Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same |
WO2001093860A1 (fr) | 2000-06-09 | 2001-12-13 | Lek Pharmaceuticals D.D. | Composition stabilisee pharmaceutiquement efficace et preparation pharmaceutique comprenant cette composition |
US20060127474A1 (en) | 2001-04-11 | 2006-06-15 | Oskar Kalb | Pharmaceutical compositions comprising fluvastatin |
TW200404544A (en) * | 2002-06-17 | 2004-04-01 | Kowa Co | Controlled release pharmaceutical composition |
WO2004026297A1 (fr) * | 2002-09-20 | 2004-04-01 | Kowa Co., Ltd. | Preparation pour usage externe |
AR041089A1 (es) | 2003-05-15 | 2005-05-04 | Merck & Co Inc | Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas |
CA2550373C (fr) | 2003-12-23 | 2012-01-31 | Merck & Co., Inc. | Composes anti-hypercholesterolemie |
JPWO2005063294A1 (ja) | 2003-12-30 | 2007-12-13 | 興和株式会社 | γ−セクレターゼ複合体形成阻害剤 |
US8314124B2 (en) | 2004-02-06 | 2012-11-20 | Active Biotech Ab | Crystalline salts of quinoline compounds and methods for preparing them |
SE0400235D0 (sv) * | 2004-02-06 | 2004-02-06 | Active Biotech Ab | New composition containing quinoline compounds |
EP1719525B1 (fr) | 2004-02-25 | 2014-12-10 | Kowa Company, Ltd. | Promoteur de transfert nuclaire pour la proteine cdc42 et methode de criblage pour celle-ci |
JP4711952B2 (ja) | 2004-02-25 | 2011-06-29 | 興和株式会社 | Racタンパク質の核内移行促進剤及びそのスクリーニング方法 |
US20060211752A1 (en) | 2004-03-16 | 2006-09-21 | Kohn Leonard D | Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression |
UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
CN101098700A (zh) | 2005-01-06 | 2008-01-02 | 默克公司 | 治疗炎性疾病的药物组合疗法和药用组合物 |
EP1726962A1 (fr) * | 2005-05-24 | 2006-11-29 | Leiden University Medical Center | Concentrations plasmatiques de lipoprotéine E pour surveiller et réduire le risque des maladies cardiovasculaires |
CN101103983B (zh) * | 2006-07-14 | 2012-09-26 | 海南盛科生命科学研究院 | 一种用碱试剂稳定的含匹伐他汀钙的药用组合物及制备工艺 |
AU2008266960A1 (en) | 2007-06-20 | 2008-12-24 | Merck Sharp & Dohme Corp. | Diphenyl substituted alkanes |
US8372877B2 (en) | 2010-04-16 | 2013-02-12 | Cumberland Pharmaceuticals | Stabilized statin formulations |
WO2012046772A1 (fr) | 2010-10-06 | 2012-04-12 | 国立大学法人東京大学 | Médicament destiné à la prévention et au traitement d'un lymphœdème |
CN103384661B (zh) | 2011-01-20 | 2016-08-10 | 默沙东公司 | 盐皮质激素受体拮抗剂 |
JP5988963B2 (ja) * | 2011-04-12 | 2016-09-07 | 沢井製薬株式会社 | ピタバスタチン含有製剤及びその製造方法 |
EP2697203B1 (fr) | 2011-04-13 | 2017-05-24 | Merck Sharp & Dohme Corporation | Antagonistes des récepteurs de minéralocorticoïdes |
WO2012153181A1 (fr) | 2011-05-11 | 2012-11-15 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | Composition pharmaceutique comprenant de la pitavastatine ou ses sels pharmaceutiquement acceptables |
CN102861018A (zh) * | 2011-07-05 | 2013-01-09 | 南京长澳医药科技有限公司 | 一种匹伐他汀钙制剂及其制备工艺 |
JP5809467B2 (ja) * | 2011-07-12 | 2015-11-11 | エルメッド エーザイ株式会社 | ピタバスタチン含有組成物及びその製造方法 |
JP5844574B2 (ja) * | 2011-08-10 | 2016-01-20 | 共和薬品工業株式会社 | ピタバスタチンを含有する安定化された薬物組成物 |
EP2765859B1 (fr) | 2011-10-13 | 2017-01-18 | Merck Sharp & Dohme Corp. | Antagonistes de récepteur des minéralocorticoïdes |
WO2014024268A1 (fr) | 2012-08-08 | 2014-02-13 | 興和株式会社 | Médicament |
CN102885797A (zh) * | 2012-10-29 | 2013-01-23 | 福州海王福药制药有限公司 | 一种含匹伐他汀钙的组合物及其制备方法和应用 |
WO2015066490A1 (fr) | 2013-10-31 | 2015-05-07 | Ohio University | Prévention et traitement de stéatose hépatique non alcoolique |
JP6649902B2 (ja) | 2014-05-30 | 2020-02-19 | ファイザー・インク | 選択的アンドロゲン受容体モジュレーターとしてのカルボニトリル誘導体 |
EP3169323A2 (fr) | 2014-07-18 | 2017-05-24 | Ohio University | Compositions d'imidazole et de thiazole permettant de modifier la signalisation biologique |
CN105343008A (zh) * | 2015-12-15 | 2016-02-24 | 青岛华之草医药科技有限公司 | 一种匹伐他汀钙组合物 |
CN107913257A (zh) * | 2016-10-10 | 2018-04-17 | 北京阜康仁生物制药科技有限公司 | 一种包含瑞舒伐他汀钙的药物组合物及其制备方法 |
JP6937195B2 (ja) * | 2017-09-01 | 2021-09-22 | 興和株式会社 | 医薬組成物 |
WO2023275715A1 (fr) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Métabolites de modulateurs sélectifs du récepteur des androgènes |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1327010C (fr) * | 1986-02-13 | 1994-02-15 | Tadashi Makino | Compositions pharmaceutiques contenant un compose anti-ulcereux de type benzimidazole et sa production |
CA1336714C (fr) * | 1987-08-20 | 1995-08-15 | Yoshihiro Fujikawa | Mevalonolactone de type quinoleine utilisee comme inhibiteurs de la biosynthese du cholesterol |
US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
JP3528186B2 (ja) * | 1991-06-24 | 2004-05-17 | 日産化学工業株式会社 | 光学活性キノリンメバロン酸のジアステレオマー塩 |
HU217629B (hu) * | 1991-12-12 | 2000-03-28 | Novartis Ag. | Eljárás fluvasztatint tartalmazó stabilizált gyógyszerkészítmények előállítására |
-
1996
- 1996-12-20 CZ CZ19972681A patent/CZ288545B6/cs not_active IP Right Cessation
- 1996-12-20 ES ES96942588T patent/ES2183023T3/es not_active Expired - Lifetime
- 1996-12-20 ZA ZA9610792A patent/ZA9610792B/xx unknown
- 1996-12-20 UA UA97084351A patent/UA29513C2/uk unknown
- 1996-12-20 SI SI9630566T patent/SI0814782T1/xx unknown
- 1996-12-20 AT AT96942588T patent/ATE228354T1/de active
- 1996-12-20 DE DE201112000014 patent/DE122011000014I1/de active Pending
- 1996-12-20 KR KR1019970705768A patent/KR100348842B1/ko not_active IP Right Cessation
- 1996-12-20 DE DE69625046T patent/DE69625046T2/de not_active Expired - Lifetime
- 1996-12-20 EP EP96942588A patent/EP0814782B1/fr not_active Expired - Lifetime
- 1996-12-20 WO PCT/JP1996/003722 patent/WO1997023200A1/fr active IP Right Grant
- 1996-12-20 RU RU97114095A patent/RU2142790C1/ru active
- 1996-12-20 AU AU11715/97A patent/AU725622B2/en not_active Expired
- 1996-12-20 DK DK96942588T patent/DK0814782T3/da active
- 1996-12-20 NZ NZ324446A patent/NZ324446A/xx not_active IP Right Cessation
- 1996-12-20 IL IL12156596A patent/IL121565A/en not_active IP Right Cessation
- 1996-12-20 SK SK1160-97A patent/SK282991B6/sk not_active IP Right Cessation
- 1996-12-20 JP JP52350097A patent/JP3276962B2/ja not_active Expired - Lifetime
- 1996-12-20 CN CNB961920653A patent/CN1137684C/zh not_active Expired - Lifetime
- 1996-12-20 PL PL96321868A patent/PL186907B1/pl unknown
- 1996-12-20 PT PT96942588T patent/PT814782E/pt unknown
- 1996-12-20 HU HU9903536A patent/HU227798B1/hu unknown
- 1996-12-20 CA CA002213608A patent/CA2213608C/fr not_active Expired - Lifetime
- 1996-12-21 TW TW085115860A patent/TW436294B/zh not_active IP Right Cessation
-
1997
- 1997-08-19 NO NO19973814A patent/NO316724B1/no not_active IP Right Cessation
- 1997-08-21 MX MX9706389A patent/MX9706389A/es unknown
-
2011
- 2011-03-17 FR FR11C0007C patent/FR11C0007I2/fr active Active
- 2011-05-04 NO NO2011006C patent/NO2011006I2/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR11C0007I2 (fr) | Composition pharmaceutique stabilisee a l'aide d'un agent de base | |
HK1010364A1 (en) | 6-Dimethylaminomethyl-1-phenyl-cyclo-hexane compounds as pharmaceutical agents | |
FR2734483B1 (fr) | Forme d'administration pharmaceutique comprenant de l'oxybutynine | |
CY2005007I1 (el) | Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη | |
FI973243A0 (fi) | Uusi farmaseuttinen yhdistelmä | |
DZ2494A1 (fr) | Composition pharmaceutique d'oméprazole. | |
ZA965368B (en) | A pharmaceutical formulation | |
IT1313549B1 (it) | Formulazioni farmaceutiche a base di epotilone 3 | |
GB9126354D0 (en) | Pharmaceutical agents | |
MA26507A1 (fr) | Compositions pharmaceutiques d'aerosol | |
FI955311A0 (fi) | Farmaseuttinen koostumuspohja | |
ZA96124B (en) | A pharmaceutical formulation | |
FR2751540B1 (fr) | Composition pharmaceutique antithrombotique | |
EP0850057A4 (fr) | Composes pharmaceutiques | |
EE9900545A (et) | Farmatseutiline kompositsioon | |
IL112639A0 (en) | A pharmaceutical composition containing pravastin | |
FR2732217B1 (fr) | Forme d'administration solide a usage oral | |
ZA964372B (en) | A pharmaceutical formulation | |
ITMI913510A1 (it) | Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita' | |
NO965448D0 (no) | Farmasöytiske forbindelser | |
ZA965367B (en) | A pharmaceutical formulation | |
FI934387A (fi) | 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner | |
ZA96122B (en) | A pharmaceutical formulation | |
FR2642331B3 (fr) | Buse d'air pour une baignoire a remous | |
FR2676364B1 (fr) | Composition pharmaceutique a base de derives d'aminobutanone. |